CROX vs SFM: How Crocs and Sprouts Farmers Market Compare (2026)

Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CROX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CROX and SFM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CROX and SFM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Crocs, Inc. designs and sells casual footwear under two brands. The Crocs Brand centers on its signature molded clog made from a proprietary closed-cell resin the company calls Croslite, extended through sandals, sneakers, and the Jibbitz charms that let buyers personalize their shoes. In 2022 Crocs acquired HEYDUDE, a lightweight casual-shoe brand, to add a second growth engine. The company sells through wholesale partners and a growing direct-to-consumer channel that includes its own websites and stores, and it markets heavily through collaborations and celebrity tie-ins. Crocs is known for operating margins well above most footwear peers, driven by a simple core product, strong pricing, and relatively low marketing spend versus sales.

Full CROX guide

Sprouts Farmers Market (Nasdaq: SFM) is a Phoenix, Arizona-based specialty grocery retailer focused entirely on fresh, natural, and organic food. The company operates a distinctive smaller-store format where fresh produce occupies the center of the store, surrounded by a curated selection of lifestyle-friendly products including organic, plant-based, keto, paleo, non-GMO, and gluten-free items. Beyond fresh produce, Sprouts carries vitamins and supplements (a high-margin category that sets it apart from conventional grocers), bulk items, dairy alternatives, seafood, deli, and bakery. Revenue is generated almost entirely through retail food sales, with margins supported by a growing private-label program (where the company has moved away from commodity products toward differentiated innovation), supplier promotions, and a self-distribution network that began expanding in May 2025 and is already improving gross margins by cutting third-party logistics costs. E-commerce (via partnerships with Instacart and DoorDash) accounts for approximately 15% of sales and mirrors in-store basket composition, reinforcing the health-focused brand positioning.

Full SFM guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CROX drivers: High-margin core Crocs Brand; Cash generation and share buybacks.
• SFM drivers: White-space store expansion; Self-distribution as a structural margin driver.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power. For SFM, the most immediate risk is comparable-store sales deceleration: growth slipped in the final quarter of fiscal 2025, as even Sprouts' relatively affluent target consumers became more price-sensitive than management anticipated.

Pick CROX if you believe its drivers more; SFM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CROX and SFM guides.

CROX. These figures are approximate, tied to the asOf date, and change with new filings and market moves, so verify live numbers before acting. A low forward P/E on Crocs reflects skepticism about whether current profitability lasts, especially given the HEYDUDE drag and single-product concentration, so the cheap multiple is a judgment about risk rather than a guarantee of value. Guidance can be revised, and tariff or demand shifts can move the numbers meaningfully.

SFM. Sprouts entered 2026 trading at a forward P/E of roughly 15x, a significant compression from the 33x multiple it commanded at the end of 2024, after comparable-store sales decelerated and the stock fell more than 50% from its peak. The consensus FY2026 revenue estimate of approximately $9.5 billion (up roughly 8% year-over-year) implies that analysts expect growth to continue, albeit at a more moderate pace. The valuation reset means the stock is now broadly in line with the industry forward P/E average of roughly 15x, so the multiple no longer prices in the exceptional growth rates of 2023 and 2024, which changes the risk-reward profile compared to a year ago.

Headline figures (approximate, Jul 2026): CROX shows revenue (annual) roughly $4 billion range across both brands, q1 2026 revenue ~$921 million, down modestly year over year, fy2026 adjusted eps guidance company guided to roughly $13.20 to $13.75 (adjusted, subject to revision), operating margin unusually high for footwear, historically in the mid-20s percent range enterprise-wide; SFM shows revenue (fy2025) ~$8.81 billion, revenue growth (fy2025 yoy) ~14%, gross margin (fy2025) ~39%, operating margin (fy2025) ~7.8%.

CROX and SFM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CROX and SFM exposure against your real portfolio. It is not an investment adviser.